Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlos Msaouel

Showing results (51-60 of 246) with videos related to

Pageof 25
Sort By:
Molecular & Cellular Oncology|September 18, 2020
Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eyePavlos Msaouel, Cheryl L Walker, Giannicola Genovese, et al.
Anticancer Research|February 11, 2015
The role of KISS1/KISS1R system in tumor growth and invasion of differentiated thyroid cancerChristos Savvidis, Eleni Papaoiconomou, Constantina Petraki, et al.
Cancers|August 26, 2022
A Causal Framework for Making Individualized Treatment Decisions in OncologyPavlos Msaouel, Juhee Lee, Jose A Karam, et al.
Cancer Investigation|October 28, 2021
Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical RegistriesAlberto Carmona-Bayonas, Paula Jiménez-Fonseca, Javier Gallego, et al.
Cells|November 10, 2023
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological MechanismsAndrew W Hahn, Neha Venkatesh, Pavlos Msaouel, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesEfstathia Papageorgiou, Nea Pitulis, Pavlos Msaouel, et al.
Anticancer Research|July 31, 2012
Dexamethasone plus somatostatin-analog manipulation as bone metastasis microenvironment-targeting therapy for the treatment of castration-resistant prostate cancer: a meta-analysis of uncontrolled studiesKonstantinos A Toulis, Dimitrios G Goulis, Pavlos Msaouel, et al.
European Urology Focus|September 17, 2024
Upfront Versus Deferred Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-analysisStepan M Esagian, Jose A Karam, Pavlos Msaouel, et al.
European Urology Focus|December 12, 2024
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis of Individual Patient DataDimitrios Makrakis, Pavlos Msaouel, Jose A Karam, et al.
Cancer Treatment and Research Communications|January 15, 2020
Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-valuesJacob J Adashek, Giannicola Genovese, Nizar M Tannir, et al.
Pageof 25

Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
Molecular & Cellular Oncology|September 18, 2020
Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eyePavlos Msaouel, Cheryl L Walker, Giannicola Genovese, et al.
Anticancer Research|February 11, 2015
The role of KISS1/KISS1R system in tumor growth and invasion of differentiated thyroid cancerChristos Savvidis, Eleni Papaoiconomou, Constantina Petraki, et al.
Cancers|August 26, 2022
A Causal Framework for Making Individualized Treatment Decisions in OncologyPavlos Msaouel, Juhee Lee, Jose A Karam, et al.
Cancer Investigation|October 28, 2021
Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical RegistriesAlberto Carmona-Bayonas, Paula Jiménez-Fonseca, Javier Gallego, et al.
Cells|November 10, 2023
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological MechanismsAndrew W Hahn, Neha Venkatesh, Pavlos Msaouel, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesEfstathia Papageorgiou, Nea Pitulis, Pavlos Msaouel, et al.
Anticancer Research|July 31, 2012
Dexamethasone plus somatostatin-analog manipulation as bone metastasis microenvironment-targeting therapy for the treatment of castration-resistant prostate cancer: a meta-analysis of uncontrolled studiesKonstantinos A Toulis, Dimitrios G Goulis, Pavlos Msaouel, et al.
European Urology Focus|September 17, 2024
Upfront Versus Deferred Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-analysisStepan M Esagian, Jose A Karam, Pavlos Msaouel, et al.
European Urology Focus|December 12, 2024
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis of Individual Patient DataDimitrios Makrakis, Pavlos Msaouel, Jose A Karam, et al.
Cancer Treatment and Research Communications|January 15, 2020
Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-valuesJacob J Adashek, Giannicola Genovese, Nizar M Tannir, et al.
Pageof 25